Bosentan

Bosentan is a medicine used to treat high blood pressure in the lungs (pulmonary hypertension) and a condition called systemic sclerosis. It works by blocking a substance called endothelin, which helps relax blood vessels. This helps the blood vessels stay open and reduces the pressure in the lungs.

Brand names:Tracleer
Medication

What people taking Bosentan report

Every report comes from a Lived member, sent anonymously.

Have you tried Bosentan for Pulmonary Arterial Hypertension?

NameHow it went

About Bosentan

What It's For

Bosentan, sold as Tracleer and as generic tablets, is a prescription medicine for pulmonary arterial hypertension (PAH). PAH is a rare, serious condition in which the small arteries of the lungs narrow and stiffen. That raises the pressure the right side of the heart must pump against, which over time causes breathlessness, tiredness and a shrinking ability to exercise, and can strain the heart. In the US, bosentan is approved for adults with PAH to improve exercise ability and slow the disease from getting worse, and for children aged 3 and older whose PAH has no identifiable cause (idiopathic PAH) or is linked to a heart defect present from birth. The trials included people whose PAH was related to scleroderma and other connective tissue diseases. The approval covers PAH specifically, not other kinds of pulmonary hypertension such as those caused by left-sided heart disease or lung disease. In Europe, bosentan is also approved to reduce new finger ulcers (digital ulcers) in people with systemic sclerosis (scleroderma), but that use is not part of its US approval. Bosentan belongs to a group of medicines called endothelin receptor antagonists, alongside ambrisentan (Letairis) and macitentan (Opsumit). It can be used together with other PAH medicines, such as sildenafil.

How It Works

Endothelin-1 is a natural substance made in the blood vessel lining that makes vessels tighten. People with PAH have higher levels of it in their blood and lung tissue, which is thought to help drive the disease. Bosentan blocks both of the receptors endothelin acts on, so it has less ability to narrow the lung arteries. In clinical studies, this lowered the pressure and resistance in the lung circulation and let the heart pump more blood with each minute. Researchers have not worked out exactly how these changes translate into better walking ability. Bosentan controls PAH rather than curing it, so its effect lasts only while it is taken.

Dosage & Administration

Bosentan is taken by mouth twice a day, morning and evening, with or without food, at about the same times each day. Teenagers over 12 and adults who weigh more than 40 kg (about 88 pounds) start on a lower dose for the first four weeks and then step up to the usual maintenance dose. Higher doses did not add enough benefit to justify the extra liver risk. Younger children take a dispersible tablet, dissolved in a small amount of water right before each dose, with the amount based on weight. The dispersible tablets contain aspartame, which matters for people with phenylketonuria (PKU). Because of its liver risk, bosentan is available only through a restricted safety program, the Bosentan REMS (Risk Evaluation and Mitigation Strategy). The prescriber, the patient and the pharmacy must all enroll, the medicine is dispensed only by registered pharmacies, and the prescriber agrees to check liver blood tests every month. If a dose is missed, take it when remembered unless the next dose is nearly due; do not take two doses together. Do not stop bosentan on your own, because PAH symptoms can worsen if it is stopped suddenly.

Side Effects

The side effects reported most often in studies were cold-like respiratory infections, headache, swelling of the legs and ankles, flushing, low blood pressure, joint pain and a pounding heartbeat (palpitations). Bosentan can also lower hemoglobin, the oxygen-carrying protein in red blood cells, which can add to tiredness and breathlessness. Blood counts are checked after one and three months and then every three months. The most important serious risk is liver injury. In studies, about 1 in 9 people had a clear rise in liver enzymes on blood tests. These rises usually cause no symptoms and often settle when the dose is lowered or paused, which is why monthly testing matters. Rarely, bosentan has been linked to liver failure. Contact the prescriber right away for yellowing of the skin or eyes, nausea or vomiting, fever, stomach pain or unusual tiredness. Fluid retention can develop within weeks of starting and is sometimes a sign of the heart struggling. Call the care team promptly for quick weight gain, increasing swelling of the feet, ankles or legs, or breathing that is harder than usual. Serious allergic reactions are rare; swelling of the face, lips, tongue or throat, or trouble breathing or swallowing, needs emergency care by calling 911.

Interactions & Warnings

Bosentan caused birth defects in animal studies and must not be taken during pregnancy. For anyone who could become pregnant, pregnancy is ruled out before starting, and effective contraception is needed before the first dose, throughout treatment and for one month after stopping. Bosentan makes hormonal birth control (pills, patches, shots and implants) less reliable, so a hormonal method should not be the only protection. Reliable choices include an intrauterine device (IUD) or tubal sterilization, or a hormonal method combined with a barrier method such as condoms. Contact the prescriber right away about a late or missed period, a possible birth control failure or a suspected pregnancy. Breastfeeding is not recommended during treatment. Bosentan has lowered sperm counts in some men, and it is not known whether any effect on fertility fully reverses. This is worth raising before starting if future children are a consideration. Two combinations are not allowed: cyclosporine, an immune-suppressing medicine used after organ transplants, which sharply raises bosentan levels; and glyburide, a diabetes pill, which increases the chance of liver problems. Bosentan also speeds the breakdown of many other medicines, lowering their levels, while some, such as the antifungal fluconazole, can push bosentan levels much higher. Ritonavir, a booster used in some HIV treatments, needs a specific plan for timing. Review every prescription, over-the-counter medicine and supplement with the prescriber and pharmacist, and check before starting anything new. Bosentan is generally not started when liver enzyme tests are already more than three times the upper limit of normal, because it becomes hard to tell whether the drug is harming the liver.

What to Expect

Bosentan is a long-term medicine. In the main trials, walking distance began to improve within about a month and the full effect developed by around two months, with people walking roughly 35 to 75 meters farther in six minutes than those on placebo. Breathlessness and day-to-day function also improved, and fewer people had their PAH worsen during the studies. Responses vary, and many people need other PAH medicines alongside or instead of bosentan over time. Progress is usually judged by symptoms, the six-minute walk test (how far a person can walk in six minutes) and heart and lung measurements. Treatment means a liver blood test every month for as long as bosentan is taken, plus blood counts every few months. If liver enzymes rise, the prescriber may lower the dose, pause the medicine or stop it, depending on how high they go. Keep taking bosentan even when feeling well, and plan any change or stop with the PAH team.

Questions to Ask Your Doctor

  1. 1.Why is bosentan a good fit for my type of PAH compared with ambrisentan, macitentan or other PAH medicines?
  2. 2.How will we judge whether it is working, and when will we reassess the plan?
  3. 3.How do the REMS enrollment and monthly liver tests work, and what happens if my liver results rise?
  4. 4.Which birth control methods will protect me reliably while I take bosentan and for the month after?
  5. 5.Do any of my current medicines or supplements interact with bosentan?

Last reviewed • Oct 2026

Educational content, not medical advice.